BU’s National Emerging Infectious Diseases Laboratories Tackles COVID-19
NEIDL scientists are working to develop a vaccine for the virus that has killed more than one million people worldwide. Doctors are just beginning to understand its intricacies—how it affects patients, how it is transmitted, and who is at greatest risk of complications and death—as well as its long-term effects. Led by director Ronald Corley, a School of Medicine professor, NEIDL researchers have been working with live samples of the novel coronavirus since March and often collaborate with the wider research community.
